Location History:
- Kleines Wiesenthal, DE (2021)
- Kleines Wiesental, DE (2019 - 2022)
- Kleires Wiesental, DE (2019 - 2023)
Company Filing History:
9 out of 13 
8 out of 769 
1 out of 1 Years Active: 2019-2023
Title: The Innovative Contributions of Hans Maag
Introduction
Hans Maag is a notable inventor based in Kleines Wiesental, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for viral infections and metabolic disorders. With a total of 10 patents to his name, Maag's work has had a profound impact on medical science.
Latest Patents
Among his latest patents, Maag has developed compounds that act as allosteric effectors against the Hepatitis B virus core protein. This innovation provides new methods for treating viral infections, including hepatitis B, by administering these compounds to patients in need. Additionally, he has created triazole carboxylic acids and related compounds that serve as glycolate oxidase inhibitors. These compounds are particularly useful in treating primary hyperoxaluria type I and kidney stones, showcasing his commitment to addressing critical health issues.
Career Highlights
Throughout his career, Hans Maag has worked with prominent organizations such as Assembly Biosciences, Inc. and Indiana University. His work in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Lee Daniel Arnold and Mark G. Bures. Their collaborative efforts have contributed to the advancement of research and innovation in the pharmaceutical industry.
Conclusion
Hans Maag's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for new treatments and advancements in medical science.